Chlorine in PDB 6zux: Crystal Structure of Thrombin in Complex with COMPOUND42A

Enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND42A

All present enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND42A:
3.4.21.5;

Protein crystallography data

The structure of Crystal Structure of Thrombin in Complex with COMPOUND42A, PDB code: 6zux was solved by M.Schafer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 71.25 / 1.94
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 70.260, 71.300, 72.450, 90.00, 100.43, 90.00
R / Rfree (%) 16.2 / 20.6

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Thrombin in Complex with COMPOUND42A (pdb code 6zux). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Thrombin in Complex with COMPOUND42A, PDB code: 6zux:

Chlorine binding site 1 out of 1 in 6zux

Go back to Chlorine Binding Sites List in 6zux
Chlorine binding site 1 out of 1 in the Crystal Structure of Thrombin in Complex with COMPOUND42A


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Thrombin in Complex with COMPOUND42A within 5.0Å range:
probe atom residue distance (Å) B Occ
H:Cl1001

b:20.1
occ:1.00
CL1 H:QQE1001 0.0 20.1 1.0
C15 H:QQE1001 1.7 19.7 1.0
C14 H:QQE1001 2.7 20.7 1.0
C16 H:QQE1001 2.7 19.2 1.0
O H:PHE227 3.2 18.4 1.0
O H:TRP215 3.4 19.3 1.0
N H:PHE227 3.5 17.8 1.0
CA H:GLY226 3.6 19.4 1.0
CG1 H:VAL213 3.6 18.1 1.0
N H:TRP215 3.6 18.2 1.0
N H:SER214 3.7 17.8 1.0
C H:TRP215 3.8 19.6 1.0
C H:GLY226 3.8 18.9 1.0
CZ H:TYR228 3.9 17.9 1.0
C H:PHE227 4.0 18.5 1.0
C13 H:QQE1001 4.0 20.6 1.0
C11 H:QQE1001 4.0 19.1 1.0
CE1 H:TYR228 4.1 18.5 1.0
OH H:TYR228 4.1 17.9 1.0
CE2 H:TYR228 4.1 17.1 1.0
CA H:TRP215 4.1 18.8 1.0
C H:SER214 4.2 18.9 1.0
CA H:PHE227 4.4 18.1 1.0
CA H:VAL213 4.4 17.3 1.0
CB H:ALA190 4.4 20.6 1.0
C H:VAL213 4.4 17.8 1.0
C12 H:QQE1001 4.5 19.7 1.0
N H:GLY216 4.5 20.1 1.0
CD1 H:TYR228 4.5 18.6 1.0
CA H:SER214 4.6 18.6 1.0
CD2 H:TYR228 4.6 17.6 1.0
CB H:VAL213 4.6 18.0 1.0
CG H:TYR228 4.7 18.4 1.0
O H:GLY226 4.8 19.9 1.0
OD1 H:ASP189 4.8 20.5 1.0
O H:SER214 4.9 20.4 1.0
O H:HOH1162 4.9 18.8 1.0
N H:TYR228 5.0 17.5 1.0
N H:GLY226 5.0 19.8 1.0

Reference:

A.Hillisch, K.M.Gericke, S.Allerheiligen, S.Roehrig, M.Schaefer, A.Tersteegen, S.Schulz, P.Lienau, M.Gnoth, V.Puetter, R.C.Hillig, S.Heitmeier. Design, Synthesis, and Pharmacological Characterization of A Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics. J.Med.Chem. V. 63 12574 2020.
ISSN: ISSN 0022-2623
PubMed: 33108181
DOI: 10.1021/ACS.JMEDCHEM.0C01035
Page generated: Sat Dec 12 14:48:36 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy